Press Release Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer’s Cognition Aug 26
Press Release Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026 Aug 7